Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma in Non-surgical Candidates: Initial Clinical Experience.

@article{Chang2016StereotacticAB,
  title={Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma in Non-surgical Candidates: Initial Clinical Experience.},
  author={Joe H. Chang and Patrick C F Cheung and Darby Erler and Marcus Sonier and Renee M Korol and William G. Chu},
  journal={Clinical oncology (Royal College of Radiologists (Great Britain))},
  year={2016},
  volume={28 9},
  pages={e109-14}
}
AIMS To report the outcomes of a cohort of patients with renal cell carcinoma (RCC) treated using stereotactic ablative body radiotherapy (SABR). MATERIALS AND METHODS Patients treated with SABR for primary RCC from 1 January 2012 to 1 April 2015 were retrospectively reviewed. Patients were non-surgical candidates treated with doses ranging from 30 to 40 Gy in five fractions. The tumour sizes and serum creatinine were compared between the pre-treatment assessment and subsequent follow-up… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 21 references

A phase 1 doseescalation study of robotic radiosurgery in inoperable primary renal cell carcinoma

SM McBride, AA Wagner, ID. Kaplan
Int J Radiat Oncol Biol Phys 2013;87:S84 • 2013
View 4 Excerpts
Highly Influenced

Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology • 2015
View 2 Excerpts

Seamless phase I/II study of stereotactic lung radiotherapy (SBRT) for early stage, centrally located, non-small cell lung cancer (NSCLC) in medically inoperable patients

A Bezjak, J Bradley, L Gaspar
RTOG 0813 [Internet] • 2015
View 1 Excerpt

Similar Papers

Loading similar papers…